DD2 - Danish Centre for Strategic Research in type 2 diabetes has announced an upcoming research seminar. This seminar will guide attendees on how to leverage the unique DD2 cohort for their research and secure funding for their projects through the Novo Nordisk Foundation.
Read MoreNoen mennesker får ikke bedret insulinfølsomhet av trening, til tross for økt VO2max og muskelstyrke. Serumproteomikk og maskinlæring kan brukes til å forutsi hvem dette gjelder, noe som på sikt kan gi bedre persontilpasset behandling.
Read MoreEn nylig publisert studie utforsker de molekylære effektene av en 12-ukers intervensjon med en kombinasjon av styrke- og utholdenhetstrening.
Read MoreA new paper authored by Professor Knut Dahl-Jørgensen explores the potential link between viral infections and the onset of type 1 diabetes.
Read MoreThe Norwegian Childhood Diabetes Registry (NCDR) has recently received significant recognition in the latest issue of Diabetes Care.
Read MoreProfessor Emeritus Knut Dahl-Jørgensen was honored with the prestigious Knud Lundbæk award from the Scandinavian Society for the Study of Diabetes (SSSD) during its Annual Meeting in Helsinki on 24 May.
Read MoreSørasiater i Norge har høy risiko for type 2 diabetes, men mekanismene bak dette er ukjent. Vi sammenlignet derfor 179 sørasiatiske og 108 nordiske kvinner etter svangerskapsdiabetes.
Read MoreSuccess in achieving International Society for Pediatric and Adolescent Diabetes’ glycemic targets varies considerably among countries. This paper seeks to evaluate how HbA1c levels and the use of diabetes technology changed in Norway from 2013 to 2022 and how different measures influence glycemic control.
Read MoreCand.med. Maryam Saeed at Institute of Clinical Medicine will be defending the thesis “Risk of Coronary Heart Disease and End-Stage Renal Disease in Type 1 Diabetes with onset before 15 years of age, 1973 - 2017” for the degree of PhD (Philosophiae Doctor).
Read MoreThe use of tissue continuous glucose monitoring (CGM) has increased exponentially the last five years. In the Norwegian diabetes registries 96% of children and 87% of adults with type 1 diabetes in Norway use this technology. The New England Journal ogf Medicine recently had a review article on diabetes technology.
Read MoreResearchers from Oslo Diabetes Research Center today present the results of the DiVID study at the annual meeting of the European Association for the Study of Diabetes in Hamburg. The study was simultaneously published in the high-ranked medical journal Nature Medicine.
Read MoreM.Sc. Nicolas Fragoso Bargas at Institute of Clinical Medicine will be defending the thesis “DNA Methylation and cardiometabolic health: associations with insuline resistance, folate, and physical activity in pregnancy” for the degree of PhD (Philosophiae Doctor).
Read MorePresentations from members of Oslo Diabetes Research Center at EASD 2023.
Read MoreResearchers from our center will present news about diabetes and diabetes research to the public at a meeting in Litteraturhuset, Oslo on Tuesday September 26, at 6 p.m.
Read MoreOur Annual report from 2022 shows a highly active year.
Read MoreOn June 14th Oslo Diabetes Research Center celebrated the annual summer party.
Read MoreSindre Lee-Ødegård has been awarded NOK 16 million in the Excellence Emerging Investigator Grant in endocrinology and metabolism from the Novo Nordisk Foundation.
Read MoreOslo Diabetes Research Centre’s annual whole-day seminar was held on March 23.
Read MoreThe 57th Annual Meeting will be held 22nd to 25th of April in Soesterberg, the Netherlands.
The abstract deadline will be 15th of January 2023 (no extensions), with confirmation of acceptance before 1st of February 2023. Please visit www.edeg2023.nl to submit your abstract, and for more information about the meeting.
Powered by Squarespace.
